The internet of things (IoT) has allowed for ubiquitous measurement. Infant incubator temperature is one of crucial parts that need to be measured, especially for the stability and uniformity temperature. Based on the interpretation of IEC 60601-2-19, we proposed measurement method using IoT with the message queue telemetry transport (MQTT). In the 10,000 packet, the result shows the quality of service (QoS) level 2 of the system has the highest delay, however it has the lowest packet loss data than the other QoS. For 1 hour, the uniformity result and stability can fulfill the standards. Uniformity of 32°C, the lowest difference is point C with 0.32 °C, and the highest difference is point B with 0.75 °C. Uniformity of 36 °C, the lowest difference is point B with 0.27 °C, and the highest difference is point C with 0.79 °C. The stability of 32 °C and 36 °C is 0.32 °C and 0.44 °C, respectively. Moreover, the Kruskal Wallis test shows the highest difference average from point M is point A and B. It occurred because of the point A and B located far from the heater part, so the point A and B colder than point C.
Cervical cancer is the one of leading cause of death for women worldwide. It occurs due to infection with the human papilloma virus (HPV) which attacks the cervix in the female reproductive organs. The detecting cervical cancer method is by using pap smears and liquid based cytology (LBC) and vaccinations. However, both methods are limited in detecting cervical cancer quickly and accurately. This study aims to find potential biomarkers that will be used to quickly detect the development of cervical cancer. Large-scale studies have shown that microRNA-205 (miRNA) regulation has a very important role in various types of cancer including cervical cancer. The extraction and synthesis of cDNA from 26 preparations of cervical cancer paraffin blocks were measured by quantitative real time PCR to evaluate the expression of miRNA-205 as a biomarker of cervical cancer in cervical cancer samples. Statistical results showed that there was a significant difference in the expression of miRNA-205 which was relatively higher in cervical cancer patients (p<0.05) miRNA-205. In addition, the increased expression of miRNA-205 is associated with an increase in the severity of cervical cancer. We conclude that miRNA-205 is a potential candidate for cervical cancer molecular biomarker.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.